SymBio Pharmaceuticals Limited (TYO:4582)

SymBio Pharmaceuticals Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3,464	3,963	6,517	6,282	3,860	3,849
Cash & Short-Term Investments	3,464	3,963	6,517	6,282	3,860	3,849
Cash Growth	-32.47%	-39.19%	3.74%	62.74%	0.30%	-1.59%
Accounts Receivable	195.63	423	913	2,084	2,148	406.99
Other Receivables	-	-	-	-	-	314.76
Receivables	195.63	423	913	2,084	2,148	721.75
Inventory	330.83	238	232	469	385.68	944.92
Prepaid Expenses	115.85	110	119	209	145.01	80.65
Other Current Assets	429.99	190	301	268	209.53	219.35
Total Current Assets	4,536	4,924	8,082	9,312	6,748	5,815
Property, Plant & Equipment	-	-	-	69	83.64	76.7
Long-Term Investments	0.02	44	87	85	-	-
Other Intangible Assets	-	-	-	222	259.1	301.84
Long-Term Deferred Tax Assets	6.68	-	-	744	1,276	-
Other Long-Term Assets	37.35	-	1	1	86.66	80.87
Total Assets	4,580	4,968	8,170	10,433	8,453	6,275
Accounts Payable	503.51	-	-	46	69.68	665.46
Accrued Expenses	-	-	-	-	516.04	-
Current Income Taxes Payable	54.94	737	872	1,564	383.6	81.93
Current Unearned Revenue	-	-	-	-	-	192.71
Other Current Liabilities	24.32	29	84	313	548.79	675.25
Total Current Liabilities	582.77	766	956	1,923	1,518	1,615
Long-Term Debt	2,340	-	-	-	-	-
Pension & Post-Retirement Benefits	4.84	4	3	3	2.78	2.05
Other Long-Term Liabilities	0	3	1	2	186.44	0
Total Liabilities	2,928	773	960	1,928	1,707	1,617
Common Stock	18,845	18,336	17,952	17,548	17,158	17,045
Additional Paid-In Capital	18,820	18,311	17,927	17,523	17,133	17,019
Retained Earnings	-36,251	-32,685	-28,852	-26,889	-27,978	-30,010
Treasury Stock	-89.89	-89	-89	-88	-86.05	-17.54
Comprehensive Income & Other	329.49	322	272	411	519.1	620.14
Shareholders' Equity	1,652	4,195	7,210	8,505	6,746	4,657
Total Liabilities & Equity	4,580	4,968	8,170	10,433	8,453	6,275
Total Debt	2,340	-	-	-	-	-
Net Cash (Debt)	1,124	3,963	6,517	6,282	3,860	3,849
Net Cash Growth	-78.09%	-39.19%	3.74%	62.74%	0.30%	-1.59%
Net Cash Per Share	23.48	87.88	163.32	158.62	99.38	116.80
Filing Date Shares Outstanding	51.95	47.83	44.75	39.52	38.37	38.17
Total Common Shares Outstanding	51.95	45.84	42.19	39.52	38.37	38.17
Working Capital	3,953	4,158	7,126	7,389	5,230	4,200
Book Value Per Share	31.81	91.52	170.89	215.22	175.78	122.01
Tangible Book Value	1,652	4,195	7,210	8,283	6,487	4,355
Tangible Book Value Per Share	31.81	91.52	170.89	209.60	169.03	114.10
Buildings	-	-	-	-	64.62	59.12
Machinery	-	-	-	-	72.73	90.04

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.